Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA.
Bioorg Med Chem Lett. 2010 Jan 1;20(1):104-7. doi: 10.1016/j.bmcl.2009.11.023. Epub 2009 Nov 14.
A series of alpha7 neuronal nicotinic acetylcholine receptor ligands were designed based on a structural combination of a potent, but non-selective ligand, epibatidine, with a selective lead structure, 2. Three series of compounds in which aryl moieties were attached via a linker to different positions on the core structure were studied. A potent and functionally efficacious analog, (3aR,6aS)-2-(6-phenylpyridazin-3-yl)-5-(pyridin-3-ylmethyl)octahydropyrrolo[3,4-c]pyrrole (3a), was identified.
基于一种强效但非选择性配体——埃皮卡定,与一个选择性先导结构——2,设计了一系列α7 型烟碱型乙酰胆碱受体配体。研究了通过连接子将芳基部分连接到核心结构不同位置的三类化合物。鉴定出一个强效且具有功能疗效的类似物,(3aR,6aS)-2-(6-苯基哒嗪-3-基)-5-(吡啶-3-基甲基)八氢吡咯并[3,4-c]吡咯(3a)。